Skip to main content

Peer Review reports

From: Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series

Original Submission
16 Aug 2021 Submitted Original manuscript
24 Apr 2022 Reviewed Reviewer Report - Filippo Confalonieri
14 May 2022 Author responded Author comments - J. Sung
Resubmission - Version 2
14 May 2022 Submitted Manuscript version 2
29 May 2022 Reviewed Reviewer Report - Filippo Confalonieri
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
12 Jun 2022 Editorially accepted
5 Aug 2022 Article published 10.1186/s13256-022-03493-6

You can find further information about peer review here.

Back to article page